New drugs may have important yet underappreciated clinical consequences in patients requiring blood transfusion. Interference with routine methods for compatibility testing for blood transfusion puts ...
(Nanowerk News) The provision of blood for patients who require repeated blood transfusions, as well as for individuals with rare blood types, presents an enormous challenge to transfusion services ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved ID CORE XT, a molecular-based assay, to be used to determine blood compatibility prior to blood ...
(HealthDay)—The U.S. Food and Drug Administration has approved the ID CORE XT DNA-based test to help doctors verify blood compatibility before a transfusion. People who need repeated transfusions, ...
Grifols sCD38 is the industry's first-ever soluble recombinant protein designed to overcome the interference that the cancer therapy daratumumab has on critical blood-transfusion tests The solution ...
Using CRISPR-Cas9–mediated gene editing, researchers based at the U.K.-based NIHR Blood and Transplant Research Unit (NIHR BTRU) in red cell products, BrisSynBio Center, and NHS Blood and Transplant ...
When you get a blood transfusion, you receive blood via an intravenous (IV) line. Blood transfusions are sometimes necessary after an injury or surgery causes a high amount of blood loss. Some people ...
Robertson D. Davenport, associate professor of pathology and medical director of the Blood Bank and Transfusion Service at the University of Michigan, explains. There are several important differences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results